gliotoxin has been researched along with Allergic Bronchopulmonary Mycosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Akbarsha, MA; Gayathri, L; Ruckmani, K | 1 |
| Desmet, K; Lagrou, K; Maertens, J; Mercier, T; Reséndiz Sharpe, A; Waumans, D | 1 |
| De Rueda, B; Delgado, MP; Domingo, MP; Gálvez, EM; Pardo, J; Revillo, MJ; Rezusta, A; Roc, L; Vidal-García, M | 1 |
3 other study(ies) available for gliotoxin and Allergic Bronchopulmonary Mycosis
| Article | Year |
|---|---|
In vitro study on aspects of molecular mechanisms underlying invasive aspergillosis caused by gliotoxin and fumagillin, alone and in combination.
Topics: A549 Cells; Aspergillus fumigatus; Cyclohexanes; Epithelial Cells; Fatty Acids, Unsaturated; Gliotoxin; Humans; Inflammation; Invasive Pulmonary Aspergillosis; Lung; Mycotoxins; Neutrophils; Reactive Oxygen Species; Sesquiterpenes | 2020 |
Gliotoxin and bis(methylthio)gliotoxin are not reliable as biomarkers of invasive aspergillosis.
Topics: Biomarkers; Bronchoalveolar Lavage Fluid; Diagnostic Tests, Routine; Galactose; Gliotoxin; Humans; Invasive Pulmonary Aspergillosis; Mannans; Prospective Studies; Serum | 2019 |
Clinical validity of bis(methylthio)gliotoxin for the diagnosis of invasive aspergillosis.
Topics: Aged; Aged, 80 and over; Biomarkers; Female; Galactose; Gliotoxin; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity | 2016 |